Correlation Between Genetic Technologies and Fisher Paykel

Can any of the company-specific risk be diversified away by investing in both Genetic Technologies and Fisher Paykel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genetic Technologies and Fisher Paykel into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genetic Technologies and Fisher Paykel Healthcare, you can compare the effects of market volatilities on Genetic Technologies and Fisher Paykel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genetic Technologies with a short position of Fisher Paykel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genetic Technologies and Fisher Paykel.

Diversification Opportunities for Genetic Technologies and Fisher Paykel

0.0

Correlation Coefficient

Genetic Technologies  Fisher Paykel

Pay attention - limited upside

The 3 months correlation between Genetic and Fisher is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Genetic Technologies and Fisher Paykel Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fisher Paykel Healthcare and Genetic Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genetic Technologies are associated (or correlated) with Fisher Paykel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fisher Paykel Healthcare has no effect on the direction of Genetic Technologies i.e., Genetic Technologies and Fisher Paykel go up and down completely randomly.

Pair Corralation between Genetic Technologies and Fisher Paykel

Assuming the 90 days trading horizon Genetic Technologies is expected to generate 457.5 times less return on investment than Fisher Paykel. In addition to that, Genetic Technologies is 7.03 times more volatile than Fisher Paykel Healthcare. It trades about 0.0 of its total potential returns per unit of risk. Fisher Paykel Healthcare is currently generating about 0.06 per unit of volatility. If you would invest  2,366  in Fisher Paykel Healthcare on October 25, 2024 and sell it today you would earn a total of  1,158  from holding Fisher Paykel Healthcare or generate 48.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Genetic Technologies  vs.  Fisher Paykel Healthcare

Genetic Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genetic Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Genetic Technologies is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Fisher Paykel Healthcare

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Fisher Paykel Healthcare are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical indicators, Fisher Paykel may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Genetic Technologies and Fisher Paykel

The main advantage of trading using opposite Genetic Technologies and Fisher Paykel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genetic Technologies position performs unexpectedly, Fisher Paykel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fisher Paykel will offset losses from the drop in Fisher Paykel's long position.

The idea behind Genetic Technologies and Fisher Paykel Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.